4.44 pm | 08 Feb 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services has maintained hold rating on Dr Reddys Laboratories with a target price of Rs 1650 in its February 3, 2012 research r...

2.54 pm | 07 Feb 2012 |  Source: Moneycontrol.com

PINC Research is bearish on Dr Reddys Labs and has recommended sell rating on the stock with a target of Rs 1519 in its February 3, 2012 research repo...

8.13 am | 06 Feb 2012 |  Source: CNBC-TV18

Piramal Healthcare | Assam Company | Uttam Galva | Lloyd Steel | Dena Bank | Syndicate Bank | SAL Steel | Hindustan Motors | Dr Reddy's Labs and Kingf...

6.14 pm | 03 Feb 2012 |  Source: CNBC-TV18

Dr Reddy’s also has slew of significant new launches lined-up ahead. It would also be launching a biosimilar product every year beginning with the Ind...

4.56 pm | 03 Feb 2012 |  Source: Reuters

Dr Reddy's , which makes generic molecules and pharmaceutical ingredients, said consolidated net profit rose to Rs 513 crore in October-December compa...

3.05 pm | 03 Feb 2012 |  Source: Moneycontrol.com

Dr Reddy's Laboratories reported a better-than-expected 88% year-on-year rise in third quarter net profit at Rs 513 crore, helped by new high margin d...

10.05 am | 03 Feb 2012 |  Source: CNBC-TV18

Pharmaceutial firm Dr Reddy's Laboratories is expected to report a profit after tax of Rs 425 crore in the third quarter of FY12, a massive growth of ...

8.00 am | 03 Feb 2012 |  Source: CNBC-TV18

Pharmaceutial firm Dr Reddy's Laboratories is expected to report a profit after tax of Rs 425 crore in the third quarter of FY12, a massive growth of ...

5.02 pm | 27 Jan 2012 |  Source: CNBC-TV18

Buy Dr Reddys Labs on dips, says Sudarshan Sukhani, s2analytics.com....

12.40 pm | 27 Jan 2012 |  Source: CNBC-TV18

Speaking exclusively to CNBC-TV18, Bino Pathiparampil, vice president of IIFL Capital says that the market should not needlessly get excited about pha...

1.37 pm | 14 Jan 2012 |  Source: Moneycontrol.com

Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...

9.56 am | 13 Jan 2012 |  Source: CNBC-TV18

Anil Manghnani, Modern Shares & Stock Brokers says, 4,860-4,880 is a key resistance for the Nifty. “I wouldn’t want to take a fresh call, unless I see...

6.20 pm | 11 Jan 2012 |  Source: Moneycontrol.com

KRChoksey has come with its December quarterly earning estimates for Pharma sector. According to the research firm, Q3FY12 is expected to be a strong ...

6.34 pm | 10 Jan 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services has come with its December quarterly earning estimates for pharmaceutical sector. According to the research firm the s...

12.02 pm | 07 Jan 2012 |  Source: Moneycontrol.com

On CNBC-TV18's show Super Six, market gurus Rajesh Jain of Religare Securities, Arunesh Madan of Augment Investment Pvt Ltd and Vishal Kshatriya of E...

10.32 pm | 02 Dec 2011 |  Source: CNBC-TV18

After a sluggish first quarter, pharma universe reported some encouraging numbers in the second quarter. This is with some support from stable growth ...

3.58 pm | 14 Nov 2011 |  Source: Moneycontrol.com

IIFL is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 1,689 in its November 14, 2011 researc...

4.59 pm | 01 Nov 2011 |  Source: Moneycontrol.com

Emkay Global Financial Services has recommended hold rating on Dr Reddys Laboratories with a target of Rs 1604, in its October 25, 2011 research repor...

1.31 pm | 01 Nov 2011 |  Source: Moneycontrol.com

Angel Broking is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1920 in its October 28, 2011 research repor...

6.21 pm | 25 Oct 2011 |  Source: CNBC-TV18

G V Prasad, VC & CEO, Dr Reddy's Laboratories tells CNBC-TV18 that North America, Russia and the Pharmaceuticals Services and Active Ingredients (PSAI...